PORTLAND, Ore., Jan. 20, 2021 /PRNewswire/ -- llied Market Research recently published a report, titled, "Cell Separation Technologies Market by Product (Instruments and Consumables), Technology (Gradient Centrifugation, Surface Markers Separation, and Filtration Based Separation), Application (Oncology Research, Neuroscience Research, Stem Cell Research, Microbiology, Immunology Research, and Other Application) and End User (Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies and Cell Banks): Global Opportunity Analysis and Industry Forecast, 2020–2027". As per the report, the global cell separation technologies industry was pegged at $8.63 billion in 2019, and is projected to reach $28.76 billion by 2027, growing at a CAGR of 15.4% from 2020 to 2027.
Major determinants of the market
Rise in number of patients suffering from chronic disease, increase in focus on personalized medicine, and rapid technological advancements drive the growth of the global cell separation technologies market. However, ethical issues regarding embryonic stem cell separation and high cost of cell-based research hamper the growth of the market. On the contrary, potential in the emerging markets is expected to create lucrative opportunities for the market players in the future.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/398
- The outbreak of Covid-19 has increased the demand for next-generation technology that enables ongoing research and advanced diagnostic testing.
- Moreover, several cell separation technology companies have offered their products to study Covid-19 infection and supplement vaccine development.
The consumables segment held the lion's share
By product, the consumables segment dominated the market in 2019, accounting for around three-fifths of the global cell separation technologies market, owing to presence of major companies offering reagent kits and magnetic beads for cell separation technology and repetitive use of these consumables. However, the instruments segment is projected to register the highest CAGR of 16.3% from 2020 to 2027, due to increase in government funding for cell-based research and technological advancements across the world.
The biotechnology and biopharmaceutical companies segment to manifest the highest CAGR by 2027
By end user, the biotechnology and biopharmaceutical companies segment is expected to register the highest CAGR of 15.9% during the forecast period. In addition, the segment held the largest share in 2019, contributing to around three-fourths of the global cell separation technologies market, due to increased focus on the R&D of protein therapeutics, monoclonal antibody, stem cells research, cryobanking, and cell-based assays development. The report includes an analysis of other segments such as research laboratories and institutes and cell banks.
North America held the largest share
By region, the market across North America held the largest share in 2019, accounting for nearly two-fifths of the market, owing to rise in prevalence of chronic diseases, emergence of demand for novel products, and high spending on medical research and drug discovery. However, the global cell separation technologies market across Asia-Pacific is anticipated to manifest the highest CAGR of 17.8% during the forecast period, due to its high population base, increase in disposable incomes, and government initiatives to boost the biotechnology industry and improve technology and processes.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/398
Major market players
- Alfa Laval Corporate AB
- Bio-Rad Laboratories, Inc.
- Becton, Dickinson and Company
- Danaher Corporation
- Corning Incorporated
- Miltenyi Biotec Inc.
- Merck KGaA
- Stemcell Technologies Inc.
- Pluriselect GmbH
- Thermo Fisher Scientific
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
SOURCE Allied Market Research